{"schema_version":"secwatch.filing_event.v1","accession":"0001367644-24-000002","form_type":"8-K","ticker":"EBS","cik":"0001367644","company_name":"Emergent BioSolutions Inc.","filed_at":"2024-01-09T23:59:59+00:00","discovered_at":"2026-05-14T18:03:23.961715+00:00","generated_at":"2026-06-07T01:24:10.626119+00:00","sec_items":["7.01","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.05,"calibrated_materiality_score":0.05,"confidence":"low","headline":"Emergent BioSolutions announces presentation at J.P. Morgan conference; no material news disclosed","bullets":["Company to present at 42nd Annual J.P. Morgan Healthcare Conference on Jan 11, 2024 at 9:00 a.m. PT.","Presenters: Interim CEO Haywood Miller and CFO Rich Lindahl.","Press release and slide deck furnished as exhibits; no financial results or guidance provided.","Filing is procedural; no material operational or financial updates."],"urls":{"canonical":"https://secwatch.observer/filing/0001367644-24-000002","json":"https://secwatch.observer/filing/0001367644-24-000002.json","markdown":"https://secwatch.observer/filing/0001367644-24-000002.md","text":"https://secwatch.observer/filing/0001367644-24-000002.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1367644/000136764424000002/0001367644-24-000002-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1367644/000136764424000002/ebs-20240109.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-07T01:24:10.626119+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}